Antitumor necrosis α treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation
Author:
Affiliation:
1. Gastroenterology Department; King's College Hospital; London UK
2. Institute of Liver Studies; King's College Hospital; London UK
Publisher
Wiley
Subject
Transplantation,Hepatology,Surgery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.24212/fullpdf
Reference5 articles.
1. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis;Joshi;Liver Int,2013
2. Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients;Mohabbat;Aliment Pharmacol Ther,2012
3. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series;Sandhu;Aliment Pharmacol Ther,2012
4. Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation;Indriolo;Aliment Pharmacol Ther,2013
5. Cholestyramine treats primary sclerosing cholangitis associated inflammatory bowel disease;Pavlidis;J Crohns Colitis,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Use of Immunomodulators, Biologic Therapies, and Small Molecules in Patients With Inflammatory Bowel Disease and Solid Organ Transplant;Journal of Clinical Gastroenterology;2024-08-14
2. Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis;Inflammatory Bowel Diseases;2023-06-10
3. Safety of biologic treatments in solid organ transplant recipients: A systematic review;Seminars in Arthritis and Rheumatism;2021-12
4. Safety of Combination Biologic and Antirejection Therapy Post–Liver Transplantation in Patients With Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2019-10-28
5. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series;Digestive and Liver Disease;2018-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3